It used to be so simple to tell someone that has depression to “buck up” or “just get over it.” With so much awareness having been brought to the disease over the last few years, people are now realizing that it is not just a state of mind, but a real disease or disorder. With that awareness, new treatments are also being introduced and explored.
One company who is at the forefront of technology when it comes to brain disorders is the Neurocore Brain Performance Centers. The company is not just trying to treat the disease, but find the root cause and treat the symptoms. One way they do that is by mapping the brain during various moments of depression so they can find what triggers those moments. Then they reteach the brain how to cope during those moments so that a patient can permanently treat the disorder.
See more information about Neurocore at Linkedin.com.
What is unique to depression is that there are several types of disorders when it comes to the disease. This makes treating it unique, in that, doctors cannot just have a fix-all that will help every patient the same. The disorder does not always develop with outside factors, which means anyone can develop the disorder at any time for any reason. Knowing this means places like Neurocore can better understand that treatment must be individualized.
Because the signs of depression are not always obvious, the disease can start to take a physical toll on patients. Because of the stigma that has existed surrounding the disorder, many people still fear admitting they may have the disease, and therefore choose to not seek treatment. This makes it difficult for places like Neurocore to help treat everyone, and find all the many variations of disorders in depression.
Another common fact regarding depression is that it is typically found in younger people ages 15 – 44, and that suicide is the second leading cause of death in young people. The connection between depression and suicide is very real, and another reason companies like the Neurocore Brain Performance Center is striving to find permanent treatments for victims of depression. Read more about Neurocore at muscletech.com.
Life Line Screening is privately run and deals with the early detection of diseases before they reach critical stages. Life Line Screening company founded in 1993, and it is based in Austin, Texas. Life Line Screening was established in Florida by Collin Scully and Timothy. The company has since expanded across the United Kingdom and USA. Life Line Screening has also partnered with numerous insurance companies, hospitals, as well as organizations like Mission Hospital, Ameriplan, and Carolina Vascular among others. Life Line Screening’s mission is to make individuals aware of unrecognized issues health issues after, which the firm encourages individuals to seek care and treatment with their physician. Besides, the organization has a vigorous marketing campaign and publications that help in reaching out the present benefits Life Line Screening.
Life Line Screening has carried out various pieces of medical research. For instance, the company conducted a clinical research that used data from three million participants who were evaluated for the presence of AAA using ultrasound imaging. Besides, the firm had partnered with Oxford University to conduct clinical research on cardiovascular diseases such as abdominal aortic aneurysm between 2008 to 2012 across Ireland and the United Kingdom. Life Line Screening is different from the standard checkup or yearly physical in that it utilizes a unique algorithm. The algorithm considers each patient’s fitness for screening before the tests are done.
The Testing That Life Line Screening Offers
Life Line Screening has a wide variety of non-invasive screening methods to evaluate the risk factors of each patient as well as the likelihood of suffering from cardiovascular issues. Some of these tests include screening for osteoporosis and ultrasounds that are painless for carotid arteries and abdominal aorta. Also, Life Line Screening has ultrasounds of the brachial ankle index, which helps in knowing when a patient is suffering from a peripheral vascular disease. Moreover, the company has EKG screenings to detect the probability of suffering from types of strokes known as atrial fibrillation. Furthermore, Life Line Screening carries out a wide variety of blood tests that can be used various cardiovascular issues early even before they cause symptoms.
Life Line Screening Social Media: www.youtube.com/user/lifelinescreening
Amicus Therapeutics is a company you should know about because it is a leader in its industry. If you want to find out what industry the company is involved in, a brief outline of its history and other interesting information, then continue to read on.
Amicus Therapeutics is a biopharmaceutical company (GoogleFinance). Their headquarters is in Cranbury, New Jersey and they are a publicly traded company. Before the company went public, various venture capital firms funded them. Some of the firms that funded Amicus Therapeutics were Canaan Partners, Radius Ventures, and New Enterprise Associates.
On the NASDAQ, the company is traded as FOLD. As for when the company was founded, it was started in 2002 and since then it has grown to become a company that employs many people.
The company was founded in 2002 (http://www.phillypurge.com/2017/08/02/amicus-therapeutics-the-fight-against-the-rare-diseases/). Amicus Therapeutics focuses mainly on rare and orphan diseases. By 2014, Amicus Therapeutics had one of the broadest portfolios of tiny molecules chaperones in the industry. Since the beginning of 2014, the company has no products that are marketed. Migalastat is the company’s lead product.
Amicus Therapeutics has received a number of grants throughout the years. One grant was to support its studies with David Geffen School of Medicine at the University of California in Los Angeles. Another grant was to support their work with with the Icahn School of Medicine’s Alzheimer’s research center.
The CEO of Amicus Therapeutics is John F. Crowley and he has worked in the industry for over 15 years. Other key figures at the company include Bradley Campbell (COO), Chip Baird (CFO) and Daphne Quimi (senior vice president).
For those interested in learning more about what Amicus Therapeutics have to offer, then visit their website. The company’s website also has information about their locations, careers and much more. Now you know more about Amicus Therapeutics, what they do and who leads the company. It’s safe to say that Amicus Therapeutics will remain a leader in the biopharmaceutical industry.